## Abstract Hydroxyurea (HU), as an inhibitor of ribonucleotide reductase (RR) through interaction with the R2 component, has been used in the treatment of malignancies. Recently, therapeutic strategies in Epstein‐Barr Virus (EBV)‐targeted lymphoma have been reported. In order to study the effect o
Genomic integration of EBV in Burkitt's lymphoma cells alters latent viral gene expression
✍ Scribed by Wolf, J; Pawlita, M; Bullerdiek, J; Jox, A; Müller-Lantzsch, N; zur Hausen, H; Diehl, V
- Book ID
- 122915787
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 164 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Somatic cell hybrids between the malignant Burkitt lymphoma cell line BL 60 and the non-malignant Epstein-Barr virus EBV) immortalized lymphoblastoid cell line (LCL) pattern of the parental BL cell line during exponential growth in tissue culture. Subcutaneous nude mouse grafts of these hybrids, how
Epstein-Barr virus (EBV)-based expression vectors were tested for cytokine gene transfer-mediated induction of an immune response against human lymphoma cells. These vectors express the EBV latent gene EBNA 1 and carry the EBV latent origin of replication (ori P) for episomal replication in transfec